Skip to main content

Month: August 2024

Boskalis half-year figures 2024: historically high result after busy and good first half year

Boskalis Bokalift 1 & Bokalift 2Boskalis Bokalift 1 & Bokalift 2Papendrecht, 15 August 2024 KEY FIGURES FIRST HALF YEAR 2024Revenue: EUR 2.07 billion (H1 2023: EUR 1.97 billion)EBITDA: EUR 553 million (H1 2023: EUR 370 million)Net profit: EUR 298 million (H1 2023: EUR 181 million)Order book: EUR 5.3 billion (End of 2023: EUR 6.0 billion)‎Royal Boskalis B.V. (Boskalis) completed a historically good first half of the year. Fleet utilization was high and there was an increase in earnings at all three divisions. Revenue increased 5% compared to last year to EUR 2.07 billion (H1 2023: EUR 1.97 billion). EBITDA increased by nearly 50% to EUR 553 million (H1 2023: EUR 370 million). Adjusted for an exceptional gain in the first half of the year, EBITDA increased by 44% compared to the same period in 2023. Net profit...

Continue reading

DOVRE GROUP’S HALF-YEAR FINANCIAL REPORT 1.1.–30.6.2024

Dovre Group Plc         Half-year financial statement         August 15, 2024, at 9:00 a.m. DOVRE GROUP’S HALF-YEAR FINANCIAL REPORT 1.1.–30.6.2024 The figures presented in this half-year financial report are not audited. Last year’s corresponding period in parentheses. The Renewable Energy segment, consisting of the operations of the windmill park construction and construction design company Suvic Oy is fully consolidated in the Group’s financial statements. The non-controlling interest (49%) is presented as a separate line item in the income statements and balance sheet. April–June 2024Net sales increased 7,5% to EUR 50.9 (47.3) millionProject Personnel: net sales EUR 25.3 (25.9) million – decrease of 2.4%. Consulting: net sales EUR 3.5 (4.0) million – decrease of 13.0% Renewable Energy: net sales EUR 22.1 million (17.4) – increase...

Continue reading

IDEX Biometrics interim report for the first half of 2024

Oslo, Norway – 15 August 2024 – IDEX Biometrics ASA’s interim report for the first half of 2024 is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Vince Graziani, Chief Executive Officer, today at 09:00 CET. The webcast presentation slide deck is also attached to this notice (link below).Link to webcast: https://idexbiometrics.videosync.fi/q2-2024 Commercial progressIn the second quarter, IDEX Biometrics card manufacturing partners continued to take important steps towards commercial production for biometric cards, including Beautiful Card Corporation receiving their letter of approval (LoA) from Mastercard in June. This LoA represents a critical enabler for banks...

Continue reading

Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis For the Six Months Ended 30 June 2024

VANCOUVER, British Columbia, Aug. 15, 2024 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V/AIM: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on its 100% owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to announce that it has released its unaudited financial statements and management, discussion and analysis (“MD&A”) for the six months ended June 30, 2024. The reports are available under the Company’s profile on SEDAR+ (www.sedarplus.ca) and on the Company’s website (www.cornishmetals.com). Highlights for the six months ended June 30, 2024 and for the period ending August 14, 2024 (All figures expressed in Canadian dollars unless otherwise stated)Appointment of Don Turvey as Chief Executive Officer (“CEO”) (news release dated August 11,...

Continue reading

Alm. Brand A/S – Interim report for Q2 and H1 2024

Interim report for Q2 and H1 2024 Satisfactory first half year with strong premium growth – Alm. Brand Group launches new DKK 150 million share buy-back programme On 1 July 2024, Alm. Brand announced that it has signed an agreement with Norwegian insurer Gard to divest the Energy & Marine business at a total price of DKK 1.6 billion. This announcement of interim financial results covers the continuing activities only. The financial results of the divested Energy & Marine business are recognised in profit/loss on discontinuing activities after tax.The insurance service result for H1 2024 was a profit of DKK 603 million (H1 2023: DKK 562 million) Alm. Brand Group is launching a new share buy-back programme for a total amount of DKK 150 million based on a satisfactory H1 profit and a solid solvency coverage ratio The insurance...

Continue reading

Financial results for H1 2024

Company announcement no. 50 Net profit of DKK 1,215 million and return on equity of 18.8% The financial statements for the first half of 2024 show a highly satisfactory net profit of DKK 1,215 million and a return on equity after tax of 18.8%. In the second quarter alone, market rates fell by only a small margin, leading to a persistently satisfactory return on the Bank’s strong excess liquidity, which is the principal reason why net interest income was 10% higher in H1 2024 than in the year-earlier period. Overall, the Bank grew its core income by 6% compared with H1 2023. Again in Q2 2024, persistently strong credit quality resulted in a net reversal of impairment charges and a positive profit impact from impairment charges for H1 2024 in the amount of DKK 37 million. Continuing net reversals underline the robustness of our retail...

Continue reading

Nilfisk reports Q2 2024 results: Organic revenue growth and continued margin improvement

Nilfisk, a leading global provider of professional cleaning products and services, reported its Q2 2024 results today with organic growth and continued gross margin improvement. Revenue was 278.4 mEUR, up 1.9 mEUR from Q2 2023. Organic growth for Q2 2024 was 2.4%. The EBITDA margin before special items (bsi) was 14.1%. Jon Sintorn, CEO of Nilfisk comments on the Q2 results: “Nilfisk delivered a solid margin improvement for Q2 2024. A strong peak season in the Consumer Business and a strong performance in EMEA. Americas saw muted demand. While in APAC there was falling demand due to market conditions. The Service Business continued to grow, driven by the solid performance in EMEA and increased attachment rates.” The ongoing gross margin improvement continued into Q2 2024 at 42.2%, up 1.8 percentage point from the same period in the prior...

Continue reading

HALF-YEAR FINANCIAL REPORT OF MARIMEKKO CORPORATION, 1 January – 30 June 2024: Marimekko’s net sales continued to grow in the second quarter, operating profit slightly behind the comparison period but cumulative operating profit improved

Marimekko Corporation, Half-year Financial Report, 15 August 2024 at 8.00 a.m. HALF-YEAR FINANCIAL REPORT OF MARIMEKKO CORPORATION, 1 January – 30 June 2024: Marimekko’s net sales continued to grow in the second quarter, operating profit slightly behind the comparison period but cumulative operating profit improved This release is a summary of Marimekko’s half-year financial report for the January-June period of 2024. The complete report is attached to this release as a pdf file and it is also available on the company’s website at company.marimekko.com under Releases & publications. The second quarter in brief Marimekko’s net sales increased by 8 percent and totaled EUR 43.7 million (40.3). Net sales were boosted in particular by the growth of wholesale sales in Finland and Scandinavia as well as increased retail sales in Finland.  Net...

Continue reading

Zealand Pharma Announces Financial Results for the First Half of 2024

Company announcement – No. 39 / 2024 Zealand Pharma Announces Financial Results for the First Half of 2024 Very strong progress across R&D pipeline followed by substantial capital raise enabling further investments to accelerate the development programs for wholly owned obesity assets.  Extremely encouraging weight loss and tolerability data announced with long-acting amylin analog petrelintide from MAD Part 2 (16-week trial) Impressive data from Boehringer Ingelheim’s Phase 2 clinical trial with survodutide in MASH presented at the EASL congress in Milan, Italy Significant strengthening of the balance sheet with completion of upsized equity offering raising gross proceeds of DKK 7 billion / USD 1 billion, which enables further investments to accelerate the development of our differentiated obesity assets resulting in a guidance...

Continue reading

DNO Reports Solid Second Quarter Results, Hikes Dividends

Oslo, 15 August 2024 – DNO ASA, the Norwegian oil and gas operator, today reported a doubling of net profit to USD 35 million on revenue of USD 137 million in the second quarter of 2024. Net production rose six percent to 79,400 barrels of oil equivalent per day (boepd), of which Kurdistan contributed 59,800 boepd, North Sea 16,300 boepd and West Africa 3,300 boepd. At the end of the quarter, the Company held cash deposits of USD 943 million and net cash of USD 158 million. The Board of Directors aims for sustainable dividends. On the back of solid results, a strong balance sheet and outlook, the Board has authorized a dividend payment of NOK 0.3125 per share in August 2024, up 25 percent from prior quarterly distributions, pursuant to the authority granted it by the Shareholders at the 2024 Annual General Meeting. DNO increased spending...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.